Cargando…
Therapeutic use of specific tumour necrosis factor inhibitors in inflammatory diseases including COVID-19
Coronavirus disease 2019 (COVID-19) has caused significant devastation globally. Despite the development of several vaccines, with uncertainty around global uptake and vaccine efficacy, the need for effective therapeutic agents remains. Increased levels of cytokines including tumour necrosis factor...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Published by Elsevier Masson SAS.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8162906/ https://www.ncbi.nlm.nih.gov/pubmed/34126316 http://dx.doi.org/10.1016/j.biopha.2021.111785 |